Virology
Delta24-hyCD adenovirus uses oncolysis and chemosensitization to fight glioma
Published in Cancer Weekly, April 12th, 2005
According to recent research from the United States, "replication-competent adenoviruses could provide an efficient method for delivering therapeutic genes to tumors. The most promising strategies among adenovirus-based oncolytic systems are designed to exploit free E2F-1 activity in cancer cells, which in the absence of pRb activates transcription and regulates the expression of genes involved in differentiation, proliferation, and apoptosis."
"We previously developed Delta24, an E1A-mutant, conditionally replicative oncolytic adenovirus. Here, we examine the ability of a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-04-12)
More Articles from Cancer Weekly
- Angiolipoma
Angiolipoma is not a metastatic tumor or a malignant vascular tumor - Leukemia
Deletion of chromosome band 5q linked to refractory myelogenous leukemia - Leukemia Therapy
Fibromodulin used as a novel tumor-associated antigen in leukemia - Soft Tissue Cancers
Myxoid MFH and pleomorphic liposarcoma shared very similar genomic imbalances - Thyroid Cancer
Silencing of tumor suppressor ARHI contributed to thyroid carcinogenesis - Actinic Keratosis
Clinical trial for non-melanoma skin cancer and actinic kertosis initiated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
